[1]
“The Impact of COVID-19 on US Clinical Trial Activity”, acbr, vol. 8, no. 3, pp. 196–203, May 2024, Accessed: Sep. 17, 2026. Available: https://fortunejournals.org/ojs/index.php/acbr/article/view/15066